Hers Launches in Australia, Expanding Personalized Women’s Healthcare Nationwide
Hims & Hers Health, Inc. has officially launched Hers in Australia, expanding its personalized digital healthcare platform to women across the country. The launch introduces specialized care programs covering hair regrowth, weight management, menopause and perimenopause, with an emphasis on evidence-based treatment options, ongoing clinical support and services designed around women’s health needs.
The launch marks the rebranding of Juniper, the women’s health platform operated by Eucalyptus that has served Australian patients since 2021. The transition follows the launch of Hims in Australia in August 2026 and builds on Hims & Hers’ acquisition of Eucalyptus earlier in the year. Together, these developments bring the company’s broader consumer healthcare platform to the Australian market under the Hims and Hers brands.
Through Hers, the company aims to provide women with a more connected healthcare experience that addresses their health concerns across different stages of life. The platform combines access to clinicians, medication where appropriate, nutrition and fitness support, and a care team available around the clock. Its approach is intended to help women navigate health conditions that may be difficult to discuss or that have traditionally received limited attention in routine healthcare settings.
The launch also expands the company’s international presence, extending its personalized digital healthcare model into Australia while maintaining the existing support structure for current Juniper patients.
Expanding Access to Personalized Women’s Healthcare
Women can experience a range of health concerns throughout their lives, including hair loss, weight-related challenges and hormonal changes associated with perimenopause and menopause. However, finding appropriate care may involve navigating different specialists, treatment options and healthcare services.
Hers is designed to connect these areas through a single digital platform. Instead of addressing each symptom in isolation, the company says its approach considers women’s broader health needs and provides access to services intended to support them over time.
The Australian launch introduces treatment programs across three primary areas: hair health, weight management, and menopause and perimenopause care. These services are intended to give women access to treatment options and professional support through a more coordinated digital experience.
For eligible patients, the platform may provide access to prescribed medication, clinical guidance and additional resources depending on their individual circumstances. Treatment decisions remain subject to clinical assessment, suitability and applicable Australian healthcare requirements.
The company is positioning Hers as a platform that combines digital convenience with professional medical oversight. Women can access services remotely, potentially reducing some of the logistical challenges associated with arranging appointments or seeking specialized care.
Digital healthcare can be particularly useful for people who live far from specialist services or who have difficulty fitting appointments around work, family responsibilities and other commitments. However, the suitability of telehealth varies according to a patient’s condition, and some individuals may still require in-person examinations, testing or specialist referrals.
By bringing several women’s health services together, Hers aims to make it easier for patients to understand their options and seek appropriate support.
Rebranding Juniper Under the Hers Name
The launch represents a significant step in the integration of Eucalyptus’ existing healthcare operations with Hims & Hers.
Juniper has served Australian patients since 2021, focusing on women’s health and weight management. Following the acquisition of Eucalyptus by Hims & Hers earlier in 2026, the Juniper platform is transitioning to the Hers brand.
The rebranding is part of a broader effort to bring the company’s international services together under a unified identity. Hims & Hers previously announced the transition of Pilot, Eucalyptus’ men’s health platform, to the Hims brand in Australia in August 2026.
With the introduction of Hers, the company completes the launch of its Hims and Hers platform brands in the Australian market.
The transition builds on Juniper’s existing presence rather than introducing an entirely new service without an established local foundation. According to the announcement, current Juniper patients will continue receiving support from the same care team and Australian practitioners.
These patients will also have the platform’s broader range of specialties and the resources associated with Hims & Hers behind the service.
Maintaining continuity is important during a healthcare brand transition because patients may already have established relationships with clinicians and care teams. Preserving those relationships can help reduce disruption while the company updates its branding and expands its services.
The company has not announced that existing patients will need to change practitioners as part of the rebranding. Its stated approach is to continue supporting current patients through their existing Australian care team.
A Weight Management Program Designed for Women
Weight management is one of the central services included in the Hers Australia launch. The company describes its offering as a women-focused approach that combines clinical expertise with ongoing support.
Weight management can involve multiple factors, including nutrition, physical activity, medical history, hormonal changes, sleep and other individual circumstances. For some patients, clinical assessment may identify a role for prescription medication alongside lifestyle changes and continued monitoring.
Hers aims to bring these elements together through a digital care experience. Depending on individual needs and clinical eligibility, patients may have access to medication options, nutrition guidance, fitness support and continuing assistance from the platform’s care team.
The company also offers a digital weight-loss companion designed to provide ongoing support through the weight-management journey.
According to Hims & Hers, the companion is informed by its own research and supported by more than 20 peer-reviewed studies focused specifically on women’s needs. The company says this research helps inform its approach to weight management and the development of related services.
Research focused on women is relevant because health experiences and treatment responses can vary across individuals and life stages. A woman’s medical history, hormonal changes, reproductive health and other factors may influence how weight-related concerns should be assessed and managed.
The company’s approach aims to provide a more continuous experience than a model centered only on individual appointments. Digital resources can help patients access information and support between clinical interactions, although they do not replace medical assessment or individualized treatment recommendations.
Patients considering weight-loss treatment should receive appropriate clinical evaluation and understand the potential benefits, risks and limitations of available options. Medication decisions must be based on individual suitability and the applicable prescribing requirements in Australia.
Through its weight-management program, Hers is seeking to combine digital access with clinical oversight and practical support for women navigating weight-related health concerns.
Hair Regrowth Care Addresses a Common but Stigmatized Concern
Hair health is another major component of the Australian launch. Hers is introducing treatment options for hair regrowth, including formulations based on clinically established treatment approaches.
Hair loss can affect women for a variety of reasons, including genetics, hormonal changes, nutritional factors, medical conditions and certain medications. The appropriate response depends on the underlying cause, making professional assessment an important part of care.
Despite its potential impact on confidence and quality of life, hair loss can remain a difficult subject for some women to discuss. Patients may struggle to find clear information about available treatments or may delay seeking help because of embarrassment or uncertainty.
Hers says its hair health offering is intended to help address these barriers by providing access to treatment options through a digital platform.
The company’s approach includes innovative formulations of clinically proven treatment options intended to support hair regrowth. The exact treatment a patient receives will depend on clinical suitability and the options available under the Australian service.
Digital access may make it more convenient for patients to begin a conversation about hair loss and learn about potential treatment pathways. However, hair loss can sometimes signal an underlying health issue, and not every type of hair loss responds to the same treatment.
Appropriate assessment can help determine whether treatment is suitable and whether additional investigation or specialist care is needed.
By including hair health alongside weight management and hormonal care, Hers aims to offer women a broader set of services through one platform.
Menopause, Perimenopause and Hormonal Health
The Australian launch also introduces services addressing menopause, perimenopause and related hormonal health concerns.
Perimenopause is the transitional period leading up to menopause, during which hormonal changes can contribute to a range of physical and emotional symptoms. Menopause marks the end of menstrual cycles and can be accompanied by changes that affect sleep, temperature regulation, mood, sexual health and overall well-being.
Experiences differ considerably from one woman to another. Some may have relatively mild symptoms, while others experience changes that affect everyday activities, work and quality of life.
Hers aims to help women better understand these life stages and access appropriate support. Its hormonal health services are designed to connect patients with clinical guidance and treatment options based on their individual needs.
The platform also references care for conditions such as PCOS, or polycystic ovary syndrome, in describing its broader focus on women’s hormonal health. PCOS is a hormonal condition that can affect menstrual cycles, skin, hair growth, metabolism and fertility, with symptoms and severity varying between individuals.
Addressing these concerns within a women’s health platform may help patients find information and clinical support without having to navigate every issue separately.
The company’s approach emphasizes understanding how different aspects of women’s health can intersect. For example, hormonal changes may be relevant when assessing hair loss or changes in weight, although these symptoms can have multiple causes and should not automatically be attributed to hormones.
Clinical assessment remains essential to determine the underlying issue and appropriate treatment.
By offering services across different stages of life, Hers aims to give women a place to seek information and care as their health needs change.
Around-the-Clock Care Team Support
A key element of the Hers platform is access to a care team 24 hours a day, seven days a week.
Ongoing access to support can help patients ask questions, seek clarification about their care and navigate their treatment journey. This may be particularly valuable for people managing conditions that require continued attention rather than a single consultation.
The platform combines access to clinicians with medication where appropriate, nutrition and fitness support, and digital resources. The company describes this model as an effort to provide continuing care rather than simply offering an isolated treatment.
Hers also says women may request a female practitioner across its specialties. This option is intended to provide greater choice for patients who prefer to discuss personal or sensitive health concerns with a female healthcare professional, subject to availability.
The company further reports that its community includes more than 27,000 women who support one another through their health journeys. Peer communities can offer opportunities to exchange experiences and feel less isolated when dealing with health concerns.
However, community experiences are not a substitute for professional medical advice. Treatment decisions and health concerns should be discussed with qualified healthcare professionals, particularly when symptoms are new, severe or changing.
The combination of clinical services, digital support and community resources is intended to give Hers users multiple ways to engage with their healthcare.
Addressing Cost, Language and Geographic Barriers
Hims & Hers has positioned the Australian launch as an effort to improve access to women’s healthcare, particularly for people who face financial or geographic barriers.
The company’s announcement cites research indicating that 50% of Australians avoid accessing healthcare mainly because of cost. It also refers to internal Juniper research conducted in May 2026, which found that 52% of Australian women surveyed felt judged about their weight by a healthcare professional. Of those women, 72% reported avoiding clinical help.
These figures are presented in the company’s announcement and reflect the cited research and survey populations. They should not be interpreted as proof that all Australian women experience the same barriers.
Nevertheless, the findings highlight concerns around affordability, stigma and the experience of seeking care. When people feel uncomfortable discussing symptoms or expect to be judged, they may delay seeking medical advice.
The company also points to the challenges facing Australians who live in regional and rural communities. Its announcement cites information indicating that nearly 30% of Australians live in regional or rural areas, where access to specialists can be limited and waiting periods may be lengthy.
For people who live far from major healthcare centers, telehealth can offer an additional way to connect with clinicians without traveling long distances for every interaction.
Digital services cannot eliminate every access barrier. Connectivity, affordability, the availability of suitable clinicians and the need for in-person care can all affect whether a virtual service meets an individual’s needs.
However, remote consultations and digital support may offer a useful alternative or complement to traditional services for eligible patients.
Rebecca Holdt, Vice President of Product, International at Hims & Hers, said Australian women deserve care that considers them as whole people rather than focusing only on individual symptoms. She emphasized that digital health can make quality care more accessible to women living in major cities as well as those who are far from specialist services.
Holdt also noted that Juniper had demonstrated demand for women’s healthcare services in Australia, and that the Hers brand would build on that existing foundation.
Local Leadership and Global Clinical Standards
The Australian operation will combine local management and clinical leadership with the broader expertise of the international Hers organization.
Gus Wood, General Manager of Australia, will oversee the market. Dr. Matt Vickers, a practicing general practitioner who has led health technology initiatives at Eucalyptus since 2019, will serve as Chief Medical Officer of Hims & Hers Australia.
Dr. Vickers holds the qualifications FRACGP, MBBS, BMedSci and AICGG, as identified in the company’s announcement. His role brings local clinical leadership to the Australian business.
Dr. Jessica Shepherd, Chief Medical Officer of Hers, will also help ensure that Hers Australia maintains the clinical standards associated with the broader brand.
This combination of local and international leadership is intended to support services that respond to Australian patients’ needs while drawing on the company’s experience in other markets.
Matt Vickers said women often prioritize family and other responsibilities while postponing attention to their own health. He highlighted concerns about symptoms being dismissed and care being delayed, emphasizing the importance of evidence-based treatment delivered by experienced clinicians.
His comments reflect the company’s position that healthcare should consider a patient’s overall well-being rather than treating each symptom as an unrelated issue.
The local leadership structure may also help the business adapt its services to Australian healthcare requirements, patient expectations and clinical practices.
Expanding Hims & Hers’ International Presence
The Australian launch builds on Hims & Hers’ expansion across North America and Europe and follows its acquisition of Eucalyptus earlier in 2026.
Australia represents another market for the company’s digital healthcare model. The company announcement cites a projection that Australia’s telehealth market could grow from approximately US$542 million to US$2.56 billion by 2034.
Such projections indicate expectations for continued expansion in digital healthcare, although actual market growth will depend on adoption, regulation, competition, healthcare funding and patient demand.
By bringing the Hers brand to Australia, Hims & Hers is extending its consumer healthcare strategy to a market where Juniper already had an established patient base.
The rebranding may also create opportunities to bring additional services and resources into the existing platform. At the same time, the company will need to maintain continuity for current patients and ensure that its offerings meet Australian clinical and regulatory requirements.
The launch therefore combines brand integration with an expansion of services across women’s health.
The launch of Hers in Australia marks a new phase in Hims & Hers’ international expansion and the integration of Eucalyptus’ healthcare platforms. Through the rebranding of Juniper, the company is bringing together services for hair regrowth, weight management, menopause, perimenopause and broader hormonal health under the Hers name.
The platform combines digital access, clinical oversight, medication where appropriate, nutrition and fitness support, and a care team available around the clock. It also offers women the option to request a female practitioner and access to a community of more than 27,000 women.
For existing Juniper patients, the company says care will continue through the same team and Australian practitioners, now supported by the broader Hers platform.
With local leadership under Gus Wood and Dr. Matt Vickers, alongside clinical oversight from Dr. Jessica Shepherd, Hims & Hers aims to expand personalized women’s healthcare in Australia while maintaining its focus on evidence-based treatment and ongoing support.
The launch reflects a wider shift toward digital healthcare models that seek to make services more convenient and responsive to individual needs. Its long-term impact will depend on clinical quality, patient experience, affordability and the platform’s ability to provide appropriate care to women across Australia’s diverse communities.
Source link: https://news.hims.com/
